| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Mammary Neoplasms, Experimental | 21 | 2018 | 494 | 2.730 |
Why?
|
| Mammary Glands, Animal | 16 | 2018 | 533 | 2.260 |
Why?
|
| Carcinogens | 8 | 2009 | 384 | 0.940 |
Why?
|
| Mammary Neoplasms, Animal | 5 | 2011 | 221 | 0.840 |
Why?
|
| Progesterone | 7 | 2005 | 513 | 0.750 |
Why?
|
| Tumor Suppressor Protein p53 | 12 | 2018 | 3552 | 0.620 |
Why?
|
| Mammary Glands, Human | 4 | 2012 | 184 | 0.610 |
Why?
|
| Estrogens | 5 | 2005 | 751 | 0.610 |
Why?
|
| Precancerous Conditions | 4 | 2012 | 1058 | 0.600 |
Why?
|
| Neoplasm Transplantation | 6 | 2014 | 1519 | 0.590 |
Why?
|
| 9,10-Dimethyl-1,2-benzanthracene | 7 | 2009 | 108 | 0.480 |
Why?
|
| Breast Neoplasms | 15 | 2018 | 15694 | 0.470 |
Why?
|
| Stromal Cells | 3 | 2014 | 825 | 0.470 |
Why?
|
| Mice, Inbred BALB C | 14 | 2018 | 2314 | 0.460 |
Why?
|
| Estrogen Receptor alpha | 5 | 2013 | 701 | 0.450 |
Why?
|
| Morphogenesis | 2 | 2012 | 337 | 0.450 |
Why?
|
| Neoplastic Stem Cells | 4 | 2016 | 1443 | 0.450 |
Why?
|
| Tetrahydronaphthalenes | 2 | 2012 | 116 | 0.420 |
Why?
|
| Tumor Stem Cell Assay | 1 | 2012 | 231 | 0.420 |
Why?
|
| Tamoxifen | 4 | 2018 | 876 | 0.410 |
Why?
|
| Laminin | 1 | 2012 | 194 | 0.410 |
Why?
|
| Adult Stem Cells | 1 | 2012 | 73 | 0.400 |
Why?
|
| Proteoglycans | 1 | 2012 | 259 | 0.400 |
Why?
|
| Biocompatible Materials | 1 | 2012 | 202 | 0.390 |
Why?
|
| Mice | 34 | 2016 | 34495 | 0.380 |
Why?
|
| Mammary Tumor Virus, Mouse | 3 | 2013 | 122 | 0.380 |
Why?
|
| Glycoproteins | 1 | 2014 | 747 | 0.370 |
Why?
|
| Epithelial Cells | 9 | 2013 | 1818 | 0.350 |
Why?
|
| Antigens, CD | 1 | 2014 | 1385 | 0.340 |
Why?
|
| Collagen | 1 | 2012 | 752 | 0.330 |
Why?
|
| Aneuploidy | 3 | 2013 | 369 | 0.320 |
Why?
|
| Lymphoma, Mantle-Cell | 1 | 2014 | 713 | 0.320 |
Why?
|
| Peptides | 1 | 2014 | 1479 | 0.310 |
Why?
|
| Chromosomal Instability | 3 | 2008 | 233 | 0.310 |
Why?
|
| Animals | 39 | 2018 | 59536 | 0.310 |
Why?
|
| Carcinoma, Intraductal, Noninfiltrating | 1 | 2012 | 674 | 0.300 |
Why?
|
| Estradiol | 3 | 2014 | 748 | 0.300 |
Why?
|
| Anticarcinogenic Agents | 2 | 2009 | 362 | 0.290 |
Why?
|
| Cell Growth Processes | 5 | 2013 | 342 | 0.270 |
Why?
|
| Models, Biological | 2 | 2012 | 3254 | 0.270 |
Why?
|
| Disease Models, Animal | 7 | 2013 | 7222 | 0.250 |
Why?
|
| Mice, Inbred NOD | 4 | 2016 | 905 | 0.240 |
Why?
|
| Quinazolines | 1 | 2009 | 923 | 0.240 |
Why?
|
| Gene Expression Regulation, Neoplastic | 4 | 2018 | 8873 | 0.230 |
Why?
|
| Genes, p53 | 3 | 2007 | 1090 | 0.220 |
Why?
|
| Mice, SCID | 4 | 2016 | 1869 | 0.210 |
Why?
|
| Breast | 3 | 2007 | 1344 | 0.210 |
Why?
|
| Carcinogens, Environmental | 1 | 2002 | 26 | 0.210 |
Why?
|
| Progestins | 1 | 2002 | 87 | 0.200 |
Why?
|
| Separase | 3 | 2013 | 32 | 0.200 |
Why?
|
| Neoplasms, Hormone-Dependent | 1 | 2003 | 342 | 0.200 |
Why?
|
| Receptors, Estrogen | 4 | 2018 | 2086 | 0.190 |
Why?
|
| Cell Transformation, Neoplastic | 6 | 2018 | 2359 | 0.190 |
Why?
|
| Pyrazoles | 1 | 2009 | 1471 | 0.180 |
Why?
|
| Female | 38 | 2018 | 141928 | 0.180 |
Why?
|
| Sulfonamides | 1 | 2009 | 1823 | 0.180 |
Why?
|
| Cell Cycle | 2 | 2014 | 2084 | 0.180 |
Why?
|
| Rats | 8 | 2010 | 6086 | 0.170 |
Why?
|
| Cell Cycle Proteins | 6 | 2008 | 2045 | 0.160 |
Why?
|
| Graft Survival | 2 | 2012 | 1062 | 0.160 |
Why?
|
| Antineoplastic Agents, Hormonal | 3 | 2018 | 840 | 0.150 |
Why?
|
| Mice, Transgenic | 6 | 2015 | 4143 | 0.150 |
Why?
|
| Immunoenzyme Techniques | 5 | 2012 | 1165 | 0.140 |
Why?
|
| Hyperplasia | 3 | 2008 | 557 | 0.140 |
Why?
|
| Cell Self Renewal | 1 | 2016 | 62 | 0.140 |
Why?
|
| Cell Division | 4 | 2004 | 2489 | 0.140 |
Why?
|
| Polycomb Repressive Complex 1 | 1 | 2016 | 89 | 0.140 |
Why?
|
| Endopeptidases | 2 | 2008 | 220 | 0.130 |
Why?
|
| AC133 Antigen | 1 | 2014 | 110 | 0.120 |
Why?
|
| Insulin-Like Growth Factor I | 4 | 2010 | 630 | 0.120 |
Why?
|
| Leukocyte Common Antigens | 1 | 2014 | 188 | 0.120 |
Why?
|
| Culture Media | 1 | 2014 | 319 | 0.110 |
Why?
|
| Estrogen Antagonists | 1 | 2014 | 184 | 0.110 |
Why?
|
| GTP Phosphohydrolases | 1 | 2015 | 336 | 0.110 |
Why?
|
| Receptors, Metabotropic Glutamate | 1 | 2013 | 63 | 0.110 |
Why?
|
| Interleukin-8 | 1 | 2015 | 519 | 0.110 |
Why?
|
| 14-3-3 Proteins | 1 | 2013 | 143 | 0.110 |
Why?
|
| Cell Size | 1 | 2013 | 136 | 0.110 |
Why?
|
| Nicotinic Acids | 1 | 2012 | 33 | 0.110 |
Why?
|
| Coculture Techniques | 1 | 2014 | 626 | 0.110 |
Why?
|
| Cyclins | 2 | 2004 | 456 | 0.100 |
Why?
|
| Stem Cell Niche | 1 | 2012 | 94 | 0.100 |
Why?
|
| Cell Differentiation | 3 | 2012 | 4078 | 0.100 |
Why?
|
| Mice, Knockout | 5 | 2009 | 5710 | 0.100 |
Why?
|
| Multipotent Stem Cells | 1 | 2011 | 52 | 0.100 |
Why?
|
| Janus Kinase 2 | 1 | 2015 | 679 | 0.100 |
Why?
|
| Cell Separation | 1 | 2013 | 612 | 0.100 |
Why?
|
| Antigens, CD19 | 1 | 2014 | 577 | 0.100 |
Why?
|
| Antigens, Viral, Tumor | 1 | 2010 | 47 | 0.090 |
Why?
|
| Proto-Oncogene Proteins c-mdm2 | 1 | 2014 | 507 | 0.090 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 3 | 2014 | 528 | 0.090 |
Why?
|
| Bone Density Conservation Agents | 1 | 2012 | 198 | 0.090 |
Why?
|
| Humans | 22 | 2018 | 261506 | 0.090 |
Why?
|
| Drug Combinations | 1 | 2012 | 621 | 0.090 |
Why?
|
| Pregnancy | 6 | 2010 | 7573 | 0.090 |
Why?
|
| Epithelium | 1 | 2012 | 720 | 0.090 |
Why?
|
| Cell Survival | 1 | 2016 | 3045 | 0.090 |
Why?
|
| Parity | 1 | 2010 | 139 | 0.090 |
Why?
|
| Blotting, Western | 4 | 2013 | 3536 | 0.090 |
Why?
|
| Mice, Inbred Strains | 1 | 2010 | 521 | 0.090 |
Why?
|
| Immunophenotyping | 1 | 2014 | 1681 | 0.090 |
Why?
|
| Disease Progression | 3 | 2013 | 6682 | 0.090 |
Why?
|
| Growth Hormone | 1 | 2010 | 226 | 0.090 |
Why?
|
| Transcriptome | 1 | 2018 | 1859 | 0.090 |
Why?
|
| Fetal Blood | 1 | 2012 | 482 | 0.090 |
Why?
|
| Wnt1 Protein | 1 | 2009 | 103 | 0.080 |
Why?
|
| Cord Blood Stem Cell Transplantation | 1 | 2012 | 362 | 0.080 |
Why?
|
| Genetic Association Studies | 1 | 2013 | 1084 | 0.080 |
Why?
|
| Celecoxib | 1 | 2009 | 200 | 0.080 |
Why?
|
| Translocation, Genetic | 1 | 2014 | 1245 | 0.080 |
Why?
|
| Cyclooxygenase Inhibitors | 1 | 2009 | 177 | 0.080 |
Why?
|
| Cells, Cultured | 2 | 2018 | 5637 | 0.080 |
Why?
|
| Chloroquine | 1 | 2007 | 53 | 0.080 |
Why?
|
| Tumor Suppressor Proteins | 2 | 2007 | 1823 | 0.080 |
Why?
|
| Immunocompromised Host | 1 | 2012 | 698 | 0.080 |
Why?
|
| Cell Proliferation | 5 | 2016 | 7226 | 0.070 |
Why?
|
| Lactation | 2 | 2005 | 210 | 0.070 |
Why?
|
| Osteoclasts | 1 | 2007 | 165 | 0.070 |
Why?
|
| Centrosome | 2 | 2007 | 95 | 0.070 |
Why?
|
| Cell Line, Tumor | 6 | 2016 | 14551 | 0.070 |
Why?
|
| Stem Cells | 1 | 2013 | 1213 | 0.070 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2012 | 1242 | 0.070 |
Why?
|
| Heterozygote | 1 | 2009 | 1020 | 0.070 |
Why?
|
| Cyclooxygenase 2 | 1 | 2007 | 483 | 0.070 |
Why?
|
| DNA-Binding Proteins | 2 | 2009 | 4821 | 0.060 |
Why?
|
| Mad2 Proteins | 1 | 2004 | 33 | 0.060 |
Why?
|
| Immunohistochemistry | 4 | 2013 | 7548 | 0.060 |
Why?
|
| Incidence | 3 | 2013 | 5673 | 0.060 |
Why?
|
| Cell Line, Transformed | 1 | 2004 | 394 | 0.060 |
Why?
|
| Tumor Suppressor Protein p14ARF | 1 | 2004 | 97 | 0.060 |
Why?
|
| Neoplasm Invasiveness | 1 | 2012 | 3981 | 0.060 |
Why?
|
| Risk | 1 | 2008 | 1972 | 0.060 |
Why?
|
| Apoptosis | 3 | 2014 | 7591 | 0.060 |
Why?
|
| Time Factors | 3 | 2013 | 12926 | 0.060 |
Why?
|
| RNA-Binding Proteins | 1 | 2009 | 984 | 0.060 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p27 | 1 | 2004 | 287 | 0.060 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2004 | 292 | 0.050 |
Why?
|
| Neoplasm Metastasis | 2 | 2013 | 5112 | 0.050 |
Why?
|
| Drug Resistance, Neoplasm | 2 | 2014 | 5178 | 0.050 |
Why?
|
| Calcium-Binding Proteins | 1 | 2004 | 545 | 0.050 |
Why?
|
| Ovariectomy | 1 | 2003 | 330 | 0.050 |
Why?
|
| Sarcoma | 1 | 2012 | 1725 | 0.050 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2013 | 4549 | 0.050 |
Why?
|
| CD24 Antigen | 2 | 2013 | 85 | 0.050 |
Why?
|
| Base Sequence | 2 | 2004 | 4917 | 0.050 |
Why?
|
| Rats, Inbred WF | 3 | 2007 | 22 | 0.050 |
Why?
|
| ErbB Receptors | 1 | 2009 | 2295 | 0.050 |
Why?
|
| Integrin beta1 | 2 | 2013 | 126 | 0.050 |
Why?
|
| Genomics | 1 | 2011 | 2738 | 0.050 |
Why?
|
| Flow Cytometry | 3 | 2013 | 3033 | 0.050 |
Why?
|
| Receptors, Progesterone | 1 | 2005 | 1392 | 0.050 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2013 | 5539 | 0.040 |
Why?
|
| BRCA2 Protein | 1 | 2002 | 358 | 0.040 |
Why?
|
| Prostatic Neoplasms | 1 | 2016 | 5767 | 0.040 |
Why?
|
| Mice, Nude | 2 | 2018 | 4307 | 0.040 |
Why?
|
| Aging | 1 | 2007 | 1582 | 0.040 |
Why?
|
| Xenograft Model Antitumor Assays | 2 | 2018 | 3821 | 0.040 |
Why?
|
| Protein Tyrosine Phosphatases, Non-Receptor | 1 | 2018 | 17 | 0.040 |
Why?
|
| Transforming Growth Factor beta | 1 | 2004 | 1130 | 0.040 |
Why?
|
| RNA, Messenger | 3 | 2014 | 6150 | 0.040 |
Why?
|
| Phenotype | 2 | 2013 | 6295 | 0.040 |
Why?
|
| Protein Kinases | 1 | 2002 | 874 | 0.040 |
Why?
|
| Adenocarcinoma | 2 | 2013 | 7789 | 0.040 |
Why?
|
| Radiation Dosage | 1 | 2002 | 1014 | 0.040 |
Why?
|
| Repressor Proteins | 1 | 2004 | 1664 | 0.040 |
Why?
|
| Chromosome Aberrations | 1 | 2004 | 1960 | 0.040 |
Why?
|
| DNA | 1 | 2004 | 2693 | 0.030 |
Why?
|
| Phosphorylation | 2 | 2013 | 4804 | 0.030 |
Why?
|
| Carcinoma | 1 | 2007 | 2578 | 0.030 |
Why?
|
| Methylnitrosourea | 2 | 2007 | 46 | 0.030 |
Why?
|
| Bone Neoplasms | 1 | 2007 | 2576 | 0.030 |
Why?
|
| Aurora Kinases | 2 | 2007 | 189 | 0.030 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2012 | 3639 | 0.030 |
Why?
|
| Mice, Inbred C57BL | 3 | 2013 | 6942 | 0.030 |
Why?
|
| Genes, Tumor Suppressor | 1 | 2018 | 1064 | 0.030 |
Why?
|
| Aurora Kinase A | 2 | 2007 | 202 | 0.030 |
Why?
|
| Mice, Mutant Strains | 2 | 2005 | 634 | 0.030 |
Why?
|
| Antineoplastic Agents | 1 | 2016 | 14289 | 0.030 |
Why?
|
| MCF-7 Cells | 1 | 2014 | 550 | 0.030 |
Why?
|
| Genes, ras | 1 | 2015 | 667 | 0.030 |
Why?
|
| Spheroids, Cellular | 1 | 2013 | 222 | 0.030 |
Why?
|
| Etoposide | 1 | 2014 | 870 | 0.030 |
Why?
|
| Demography | 1 | 2013 | 435 | 0.030 |
Why?
|
| Cellular Senescence | 1 | 2014 | 382 | 0.030 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2008 | 2508 | 0.030 |
Why?
|
| Galactosides | 1 | 2011 | 26 | 0.030 |
Why?
|
| Tissue Array Analysis | 1 | 2013 | 760 | 0.030 |
Why?
|
| Claudins | 1 | 2011 | 47 | 0.020 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2013 | 1062 | 0.020 |
Why?
|
| Transcription Factors | 1 | 2005 | 5270 | 0.020 |
Why?
|
| Comparative Genomic Hybridization | 1 | 2013 | 691 | 0.020 |
Why?
|
| Receptors, Androgen | 1 | 2016 | 878 | 0.020 |
Why?
|
| Biomarkers | 2 | 2013 | 5047 | 0.020 |
Why?
|
| Cell Lineage | 1 | 2013 | 668 | 0.020 |
Why?
|
| Genes, Neoplasm | 1 | 2011 | 324 | 0.020 |
Why?
|
| Pregnancy, Animal | 1 | 2010 | 92 | 0.020 |
Why?
|
| Staining and Labeling | 1 | 2011 | 429 | 0.020 |
Why?
|
| Biomarkers, Tumor | 1 | 2008 | 10331 | 0.020 |
Why?
|
| Metaphase | 1 | 2008 | 107 | 0.020 |
Why?
|
| Down-Regulation | 1 | 2014 | 2074 | 0.020 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2012 | 1217 | 0.020 |
Why?
|
| Rats, Wistar | 1 | 2010 | 562 | 0.020 |
Why?
|
| Cluster Analysis | 1 | 2011 | 1053 | 0.020 |
Why?
|
| Chromatids | 1 | 2008 | 78 | 0.020 |
Why?
|
| Anaphase | 1 | 2008 | 44 | 0.020 |
Why?
|
| Signal Transduction | 3 | 2015 | 11965 | 0.020 |
Why?
|
| Tetracycline | 1 | 2008 | 90 | 0.020 |
Why?
|
| Nucleotidyltransferases | 1 | 2008 | 82 | 0.020 |
Why?
|
| Cell Transplantation | 1 | 2008 | 85 | 0.020 |
Why?
|
| Risk Factors | 1 | 2005 | 17523 | 0.020 |
Why?
|
| Colony-Forming Units Assay | 1 | 2008 | 249 | 0.020 |
Why?
|
| Immunoblotting | 1 | 2010 | 886 | 0.020 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2013 | 2232 | 0.020 |
Why?
|
| Specific Pathogen-Free Organisms | 1 | 2007 | 93 | 0.020 |
Why?
|
| Nucleic Acid Hybridization | 1 | 2008 | 542 | 0.020 |
Why?
|
| Paclitaxel | 1 | 2014 | 1996 | 0.020 |
Why?
|
| Doxorubicin | 1 | 2014 | 3005 | 0.020 |
Why?
|
| Polyploidy | 1 | 2007 | 73 | 0.020 |
Why?
|
| Dinoprostone | 1 | 2007 | 208 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2010 | 1489 | 0.020 |
Why?
|
| Homozygote | 1 | 2008 | 717 | 0.020 |
Why?
|
| Stem Cell Transplantation | 1 | 2013 | 1360 | 0.020 |
Why?
|
| Transplantation, Homologous | 1 | 2012 | 2843 | 0.020 |
Why?
|
| Gene Expression Profiling | 2 | 2008 | 5159 | 0.020 |
Why?
|
| Ataxia Telangiectasia Mutated Proteins | 1 | 2007 | 430 | 0.020 |
Why?
|
| Neoplasms, Experimental | 1 | 2009 | 750 | 0.020 |
Why?
|
| Menopause | 1 | 2005 | 159 | 0.020 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2005 | 448 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2010 | 2063 | 0.020 |
Why?
|
| Karyotyping | 1 | 2007 | 1022 | 0.020 |
Why?
|
| Pituitary Gland | 1 | 2005 | 150 | 0.020 |
Why?
|
| Embryo, Mammalian | 1 | 2008 | 741 | 0.020 |
Why?
|
| United States | 1 | 2002 | 15433 | 0.020 |
Why?
|
| Bromodeoxyuridine | 1 | 2004 | 139 | 0.020 |
Why?
|
| DNA Copy Number Variations | 1 | 2011 | 1516 | 0.020 |
Why?
|
| Ki-67 Antigen | 1 | 2005 | 666 | 0.010 |
Why?
|
| Cyclin D1 | 1 | 2005 | 576 | 0.010 |
Why?
|
| Cell Line | 1 | 2011 | 5114 | 0.010 |
Why?
|
| Nuclear Receptor Coactivator 3 | 1 | 2005 | 383 | 0.010 |
Why?
|
| Genome, Human | 1 | 2011 | 1869 | 0.010 |
Why?
|
| beta-Galactosidase | 1 | 2002 | 211 | 0.010 |
Why?
|
| Injections, Intralesional | 1 | 2002 | 164 | 0.010 |
Why?
|
| Ganciclovir | 1 | 2002 | 174 | 0.010 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2004 | 476 | 0.010 |
Why?
|
| Thymidine Kinase | 1 | 2002 | 193 | 0.010 |
Why?
|
| Xenopus Proteins | 1 | 2002 | 185 | 0.010 |
Why?
|
| Disease-Free Survival | 1 | 2013 | 10001 | 0.010 |
Why?
|
| DNA, Complementary | 1 | 2002 | 869 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2013 | 9244 | 0.010 |
Why?
|
| Antigens, Neoplasm | 1 | 2007 | 1506 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2005 | 2054 | 0.010 |
Why?
|
| Up-Regulation | 1 | 2004 | 2450 | 0.010 |
Why?
|
| MicroRNAs | 1 | 2011 | 2947 | 0.010 |
Why?
|
| Adenoviridae | 1 | 2002 | 1459 | 0.010 |
Why?
|
| Male | 3 | 2016 | 123000 | 0.010 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2005 | 2488 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 2002 | 4233 | 0.010 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2002 | 1498 | 0.010 |
Why?
|
| Gene Expression | 1 | 2004 | 3570 | 0.010 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2013 | 10035 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2002 | 6089 | 0.010 |
Why?
|
| Antiviral Agents | 1 | 2002 | 1230 | 0.010 |
Why?
|
| Young Adult | 1 | 2013 | 21445 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2013 | 29902 | 0.010 |
Why?
|
| Aged | 1 | 2013 | 70117 | 0.000 |
Why?
|
| Adult | 1 | 2013 | 77950 | 0.000 |
Why?
|
| Middle Aged | 1 | 2013 | 86204 | 0.000 |
Why?
|